ARTICLE / CLIENT ALERT
Negative Option Offers: How the FTC’s Proposed Rule Could Affect Your Business
April 26, 2023
Read time: 6 min
In March 2023, the Federal Trade Commission (FTC) proposed tightened requirements on the Negative Option Rule in an effort to combat unfair or deceptive practices such as recurring charges for products or services that consumers do not want and cannot cancel without undue difficulty. Negative options include offers and features such as automatic renewals, free-to-pay and fee-to-pay conversions, prenotification plans and continuity programs. The FTC seeks to increase negative option requirements for marketers to avoid any deception or hindrance to consumers who wish to cancel or opt out of subscriptions, notifications or similar programs.
The FTC understands that consumers like free trials and recurring subscriptions, but the agency wants companies to clearly disclose any applicable fees and make it easier for consumers to cancel such offers. The FTC’s proposed rule would expand the Negative Option Rule to apply to essentially any offer or provision under which a consumer’s failure to take affirmative action (i.e., silence) is interpreted as acceptance of the offer. The FTC’s proposed rule also would impose heightened consent and disclosure requirements and would create an independent violation for general misrepresentation or omission claims separate and apart from the negative option offer. Finally, if the proposed rulemaking goes into effect, it would permit the FTC to seek monetary penalties for noncompliance with the rule. Although a business could ultimately challenge these broadened requirements in court, the FTC’s proposed rule aims to deter certain behaviors and business practices by marketers and advertisers.
Several elements of the FTC’s proposed rulemaking would have significant ramifications for an advertiser’s business:
- Clear and Conspicuous Disclosures. Although the FTC has not altered what a company needs to disclose, the proposed rule would change how companies must disclose such information. The proposed rule would require the disclosure to be made through the same means as the advertising communication. Thus, if the communication made is both visual and audible (e.g., a television ad), the advertiser would have to present the disclosure both visibly and audibly. The FTC has taken the position that a disclosure is not considered clear and conspicuous if a consumer must take any action (e.g., clicking on a hyperlink or hovering over an icon) to see the disclosure. The FTC would take the position that the disclosure must be on the same page as the claim, and it cannot be within an unavoidable link. Thus, the best practice for a business would be to disclose all information relevant to the negative option offer immediately next to the means of obtaining the consumer’s consent or the negative option feature. If the claim is not materially relevant to the negative option offer, advertisers should place disclosers before consumers “add to cart.”]
- Consent. Contrary to the existent “expressed informed consent” requirement, the FTC’s proposed rule would heighten consent requirements for sellers to obtain “unambiguously affirmative consent” to the negative option separate and apart from any other part of the transaction and to obtain unambiguously affirmative consent to the rest of transaction, as well. The FTC proposes that the request for consent must be “free of any information that may serve as a distraction” and “any information not directly related to the material terms and conditions of any negative option feature.” FTC Proposed Negative Option Rule, 16 CFR Part 425, RIN 3084-AB60 at 32, 45. The proposed rule notes that consent could be sufficient “if th[e] seller obtains the required consent through a check box, signature, or other substantially similar methods which the consumer must affirmatively select or sign to accept the Negative Option Feature and no other portion of the transaction.” Id. At 49. However, the rule raises the question of how to determine what constitutes “the rest” of a transaction. ]
- Simple Cancellation (“Click to Cancel”). The FTC proposes a “cancellation mechanism that mirrors the customer’s method of enrollment.” Its proposed “click-to-cancel” provision would further require companies “to provide an accessible cancellation mechanism on the same website or web-based application used for sign-up.” Id. at 33, 51. Currently, under the Restore Online Shoppers’ Confidence Act, businesses must provide consumers with a simple cancellation mechanism, but this new proposal would require companies to make cancellation at least as easy as enrollment and to provide cancellation options through the same medium the consumer used to enroll. The proposed rule also states that “[t]he seller must immediately cancel the Negative Option Feature upon request from a consumer, unless the seller obtains the consumer’s unambiguously affirmative consent to receive a Save prior to cancellation.” The FTC does not define “immediately,” however. Id. at 81. Further, the FTC provides little insight into whether companies can introduce any friction into the cancellation process—for example, by asking questions to understand why a consumer is canceling.
- Annual Reminders for Negative Option Features Not Involving Physical Good. The proposed rule states that “it is a violation of this Rule and an unfair act or practice in violation of Section 5 of the FTC Act for a Negative Option Seller to fail to provide consumers reminders, at least annually, identifying the product or service, the frequency and amount of charges, and the means to cancel.” Id. at. 82. The FTC has not provided details regarding what constitutes “annual,” but it is clear that reminders should be sent through the same medium that the consumer used to enroll.
Once the proposed rulemaking is published in the Federal Register, the public and stakeholders will have 60 days to submit comments. If your company is engaged in any of these practices, consider examining your company’s current negative option practices (including disclosures made), how consumer consent is obtained, the cancellation process and the overall user experience to see if you are compliant with the current proposal. If such compliance would not be practical or possible, or would be unduly burdensome, consider submitting a public comment before any proposed rules are finalized.

Tax Court Tells IRS It Cannot Assess or Collect Certain Tax Penalties
ARTICLE / CLIENT ALERT
Tax Court Tells IRS It Cannot Assess or Collect Certain Tax Penalties
April 25, 2023
Read time: 6 min
On April 3, 2023, the US Tax Court issued its opinion in Farhy v. Commissioner, holding that the Internal Revenue Service (IRS) lacked the statutory authority to both assess tax penalties under Internal Revenue Code (Code) Section 6038(b) and collect said penalties via a levy against the taxpayer.
The decision in Farhy is significant because the IRS regularly assesses civil tax penalties for the late filing of international information return forms, such as Form 5471, Information Return of US Persons with Respect to Certain Foreign Corporations. Moreover, for any taxpayer who paid a penalty for filing Form 5471 late, arguably the assessment of that penalty was improper, and the taxpayer may be able to seek a refund of the penalty paid.
THE FARHY DECISION
Code Section 6038(b)(1) provides a civil tax penalty of $10,000 for each year a taxpayer fails to timely file Form 5471. If the IRS sends the taxpayer notice of its failure to file, the taxpayer has 90 days after the notice is mailed to comply with the filing requirement. Failure to comply within the 90-day period subjects the taxpayer to an additional penalty of $10,000 for each 30-day period, with a maximum penalty of $50,000. (See Code Section 6038(b)(2).) Farhy had failed to file Form 5471 with his 2003 to 2010 US federal income tax returns, so the IRS assessed penalties. Farhy argued that the IRS did not have the power to assess the penalties under Code Section 6038.
The Tax Court agreed with Farhy and held that the Code does not contain any provision that permits the IRS to assess the penalty provided in Code Section 6038(b). As such, although the IRS correctly determined that Farhy should be penalized for failing to file Form 5471 with his returns, the IRS lacked the statutory ability under the Code to assess and collect the penalty under the assessment and collection procedures.
The Tax Court did note that the IRS had other tools at its disposal to collect the penalties, for example, 28 U.S.C. § 2461(a), which provides:
Whenever a civil fine, penalty or pecuniary forfeiture is prescribed for the violation of an Act of Congress without specifying the mode of recovery or enforcement thereof, it may be recovered in a civil action.
This would mean that the federal government would be required to bring an action against the taxpayer in district court to collect a penalty for failing to file Form 5471. The civil action is a procedure that is not common, thus making the penalty improbable to apply to many taxpayers.
THE IRS’S POWER TO ASSESS AND COLLECT CIVIL TAX PENALTIES
The Code provides specific rules that permit the IRS to assess taxes (including interest and additions to tax) and certain types of civil tax penalties (so-called “assessable penalties”). For example, Code Section 6201(a) permits the IRS to “assess” taxes and assessable penalties. Assessment is the act of formally recording a tax liability on the IRS’s records. After an assessment and the taxpayer’s failure to pay, the IRS can then enforce the collection of tax, penalties and interest by asserting a lien on property or by levying property. (See e.g., Code Sections 6330 and 6331.)
The power to assess, however, is not universally applicable to all civil tax penalties. Indeed, in Farhy, the Tax Court reminded the IRS and taxpayers that, unless a civil tax penalty is specifically enumerated as assessable, the IRS cannot use its power to collect the penalty under Title 26 of the Code. The Court rejected the IRS’s argument that its assessment power in Code Section 6201 covers “all penalties, or virtually any exaction, imposed by the Code simply because it covers taxes and certain other exactions specifically included.” The Court provided examples of the myriad of penalty provisions in the Code, as well as where the IRS’s authority to assess each penalty is found:

OTHER PENALTIES THAT MAY NOT BE ASSESSABLE
The Farhy decision highlights a technical obstacle in the Code with respect to the IRS’s ability to assess other types of civil tax penalties, especially those tied to international information return filings that have been a boon for the IRS in terms of collections in recent years.
Below are some of the other international information returns filing obligations whose penalty provisions fail to include the language “assessed and collected in the same manner as taxes” and thus may not be assessable under the Farhy decision:

Taxpayers that have made payment of these penalties may consider seeking a refund of such amounts paid if the relevant statute of limitations remains open.
Practice Point: Farhy is a noteworthy taxpayer victory and demonstrates that the Code fails to provide the IRS the ability to collect certain civil tax penalties. If the IRS cannot assess a civil tax penalty, then it cannot use its statutory power under the Code to collect non-assessable penalties. This may not be what Congress intended, but in the absence of a statutory fix, the IRS is now powerless to assess and collect numerous civil tax penalties.
It is important to note that the ruling does not automatically vitiate the penalties, but instead prevents the IRS from collecting them in a practicable manner. In the wake of this ruling, we expect that the IRS will cease all collection activities with respect to Code Section 6038(b) penalties and seek Congress’s assistance in providing the necessary statutory basis for the assessment and collection of these penalties. It of course remains important for taxpayers to comply with the various information reporting requirements under the Code, but any taxpayer who was assessed and paid a penalty on a late-filed Form 5471—or any of the other IRS forms discussed above—should consult with their tax advisor about whether to seek a refund of the penalty paid.

2023 Health Report
ARTICLE / REPORT
2023 Health Report
April 2023
Read time: 2 min
The healthcare industry, historically viewed as recession proof, has not been immune to the macroeconomic factors of 2023. The record-high valuations and frenetic deal activity of the past several years slowed midway through 2022 and healthcare companies, providers and investors are adjusting their expectations and strategies, all against a backdrop of regulatory scrutiny into healthcare mergers and acquisitions (M&A), investing and the end of the COVID-19 public health emergency (PHE).
Our team of industry-leading health lawyers and health policy insiders examined the industry across several sectors, reflecting on 2022’s most influential developments and how they will shape healthcare in 2023. In doing so, several key themes emerged:
- Dealmaking is complicated but still possible
- Shifting approaches to oversight
- Evolution of care delivery continues
- Creativity takes the front seat

Tennessee Joins the Fray as Legislature Passes Consumer Privacy Law
ARTICLE / CLIENT ALERT
Tennessee Joins the Fray as Legislature Passes Consumer Privacy Law
April 25, 2023
Read time: 7 min
We said it earlier this month: With many state legislative sessions coming to an end, we were likely to see a push by states to finish up debates and votes on consumer privacy laws, and now you can count Tennessee (and Montana) among those states doing just that. The Tennessee Information Protection Act (TIPA) has passed both houses of the Tennessee legislature and heads to Governor Bill Lee’s desk. We anticipate that he will sign the bill into law. The TIPA closely tracks the laws in Connecticut and Virginia, which is good news for many companies that are already subject to those laws; however, there are some wrinkles, as we discuss below. The TIPA will go into effect on January 1, 2025.
Below we provide an overview of some of the key aspects of Tennessee’s new consumer privacy law.
To Whom Does the TIPA Apply?
The TIPA takes a Utah-like approach to applicability, including both a revenue threshold and a processing volume threshold. Specifically, the TIPA applies to companies that do business in Tennessee or target products or services to Tennessee consumers and:
- Have more than $25 million in “revenue;” and
- Control or process personal information of 175,000 or more Tennessee consumers; or
- Control or process personal information of 25,000 or more Tennessee consumers and derive over 50% of gross revenue from the sale of that data.
The TIPA does not define “revenue” but, like California and Utah, we believe that the way that term will be defined is annual gross revenue on a worldwide basis.
Who Is a “Consumer”?
In the TIPA, a “consumer” is a natural person who is a resident of Tennessee acting in a personal context. This means that employees and B2B contacts are expressly excluded from the definition of “consumer.”
What Is “Personal Information”?
“Personal information” in the TIPA is “information that is linked or reasonably linkable to an identified or identifiable individual.” It excludes, however, deidentified data, aggregate data and publicly available data. The limitations for deidentified data and publicly available data closely track those of Virginia (e.g., deidentification requires a public commitment to keep data deidentified, and public data is both from government files as well as data that is generally available through mass media sources).
Although not expressly excluded from the definition of “personal information,” just as in Virginia, companies do not need to include pseudonymous data (under certain circumstances) when responding to consumer requests under the TIPA.
Who Can Enforce?
The Tennessee Attorney General has exclusive enforcement authority, and there is an express provision disclaiming any private right of action. Before initiating any enforcement proceeding, the Attorney General must give 60 days’ written notice and an opportunity to cure to the controller. If an enforcement action follows, violations of the TIPA are up to $7,500 per violation.
The TIPA does, however, also allow for an “affirmative defense” for companies that adopt privacy programs that (1) “reasonably conform” to the NIST privacy framework; (2) which program is updated regularly; and (3) afford Tennessee consumers the rights afforded under the TIPA.
Who Is Exempt?
The exemptions to the TIPA closely mimic those of other state privacy laws. For example, personal information is covered by laws such as the Health Insurance Portability and Accountability Act (HIPAA), the Children’s Online Privacy Protection Act (COPPA), the Gramm-Leach-Bliley Act, the Family Educational Rights and Privacy Act, and a litany of other federal laws.
In addition, the TIPA does not apply to government entities, nonprofit organizations or higher education institutions.
The TIPA also exempts the use of personal information for certain specific purposes, such as compliance with law, preventing fraud or injury to others and defending legal claims, just as in Virginia.
What Obligations Are Imposed?
Under the TIPA, controllers must:
- Limit the purpose of processing personal information to that which is reasonably necessary and proportional;
- Take steps to implement reasonable safeguards for the personal information within their control;
- Refrain from discriminating against consumers for exercising their rights and from processing personal information in violation of federal laws that prohibit discrimination;
- Be transparent in their reasonably accessible, clear and meaningful privacy notice; and
- Ensure contracts control relationships with their processors (note: the law itself details the minimum necessary provisions of these contracts).
What Consumer Rights Are Created by the TIPA?
Controllers must provide a now-standard set of consumer rights to Tennessee consumers:
- Opt-out rights related to the sale of personal information, targeted marketing and profiling (automated decision-making that could have significant legal effects such as related to housing, drinking water, credit, etc.);
- Deletion rights (with respect to the data provided by or about the consumer);
- Access rights, including a right to confirm whether the controller is processing any data at all;
- Correction rights, but limited to data the consumer previously provided;
- Appeal rights; and
- Data portability rights, but limited to data the consumer previously provided.
Sensitive Personal Information
Under the TIPA, “sensitive data” is considered personal information that includes information such as racial/ethnic origin, religious beliefs, mental or physical health diagnosis, sexual orientation, citizenship or immigration status, genetic or biometric information used to uniquely identify an individual, personal information collected from a known child (under the age of 13) and precise geolocation (location within a radius of 1,750 feet). Under the TIPA, a controller may not process (including collection) sensitive data without obtaining the consumer’s consent or, in the case of a child, complying with COPPA.
Response to Consumer Inquiries
As has become something of a standard in state consumer privacy laws, controllers must respond to a consumer personal information request within forty-five (45) days of receipt of the request, with a forty-five (45) day extension available. If a consumer appeals a decision of the controller to deny a consumer request, the appeal response must be delivered within sixty (60) days. As in Virginia, if the appeal is denied, controllers must provide the consumer with a method for contacting the attorney general.
Data Protection Impact Assessments
Just as the laws that the TIPA is modeled after, controllers will need to document impact assessments before they engage in a number of different processing activities, including: (i) processing for targeted marketing; (ii) sale of personal information; (iii) processing of personal information for profiling if the profiling presents a reasonably foreseeable risk of legal, deceptive, discriminatory, financial, reputational or physical harms; (iv) processing sensitive data; and (v) a catch-all category of any processing activities involving personal information “that present a heightened risk of harm to consumers.”
As in Virginia, Colorado, Connecticut and elsewhere, these impact assessments must analyze the benefits of the processing to the company, consumer and public, while weighing the harms and potential mitigants. Thankfully, the TIPA allows for the use of impact assessments done under other state laws to count towards the requirements of the TIPA and does not require retroactive impact assessments for processing activities occurring prior to the effective date of the law. However, the TIPA does expressly specify that assessments must be created or generated on or after July 1, 2024, and are not retroactive.
When Does the TIPA Take Effect?
The TIPA comes into effect on July 1, 2025.
***
Creating a successful and effective, comprehensive privacy program for your organization requires a thorough understanding of both the relevant legal obligations and the personal information subject to compliance. Setting up a program that is prepared to respond to various state privacy laws as they come into effect will save organizations time in the long run, especially as many of these laws reflect one another.
If you have questions or need assistance in readiness work for the new state consumer laws, please contact your regular McDermott lawyer or reach out to David Saunders.
Check out our additional coverage on new state consumer privacy laws:
Consumer Privacy Law Comes to Big Sky Country as Montana Passes New Law
Indiana Passes Consumer Privacy Bill
Iowa’s New Privacy Law: The Basics
Colorado Finalizes Sweeping New Privacy Rules; Iowa Joins the Fray
Preparing for New Consumer Privacy laws in Colorado, Connecticut and Utah

Consumer Privacy Law Comes to Big Sky Country as Montana Passes New Law
ARTICLE / CLIENT ALERT
Consumer Privacy Law Comes to Big Sky Country as Montana Passes New Law
April 25, 2023
Read time: 7 min
We said it earlier this month: With many state legislative sessions coming to an end, we were likely to see a push by states to finish up debates and votes on consumer privacy laws. Now you can count Montana (and Tennessee) among those states doing just that. The Montana Consumer Data Privacy Act (MCDPA) has passed both houses of the Montana legislature and heads to Governor Greg Gianforte’s desk. We anticipate that he will sign the bill into law. The MCDPA tracks the laws in Connecticut and Virginia, indicating that that model is becoming the basis for other state consumer privacy laws. The MCDPA will go into effect on October 1, 2024.
Below we provide an overview of some of the key aspects of Montana’s new consumer privacy law.
To Whom Does the MCDPA Apply?
The thresholds for the MCDPA are one of the most unique aspects of the bill. The MCDPA applies to companies that do business in Montana or target products or services to Montana consumers and:
- Control or process personal data of 50,000 or more Montana consumers (excluding personal data controlled or processed solely for the purpose of completing a payment transaction); or
- Control or process personal data of 25,000 or more Montana consumers and derive over 25% of gross revenue from the sale of that data.
Who Is a “Consumer”?
In the MCDPA, a “consumer” is a natural person who is a resident of Montana acting in a personal context. This means that employees and B2B contacts are expressly excluded from the definition of “consumer.”
What Is “Personal Data”?
“Personal Data” in the MCDPA is “information that is linked or reasonably linkable to an identified or identifiable individual.” It excludes, however, deidentified data and publicly available data. The limitations for deidentified data and publicly available data closely track those of Virginia (e.g., deidentification requires a public commitment to keep data deidentified, and public data is both from government files as well as data that is generally available through mass media sources).
Although not expressly excluded from the definition of “personal data,” just as in Virginia, companies do not need to include pseudonymous data (under certain circumstances) when responding to consumer requests under the MCDPA.
Who Can Enforce?
The Montana Attorney General has exclusive enforcement authority, and there is an express provision disclaiming any private right of action. Before initiating any enforcement proceeding, the Attorney General must give 60 days’ written notice and an opportunity to cure to the controller. This cure period, however, expires after April 1, 2026. The MCDPA does not expressly state a maximum damages amount.
Who Is Exempt?
The exemptions to the MCDPA closely mimic those of other state privacy laws. For example, personal information is covered by laws such as the Health Insurance Portability and Accountability Act (HIPAA), the Children’s Online Privacy Protection Act (COPPA), the Gramm-Leach-Bliley Act, the Family Educational Rights and Privacy Act, and a litany of other federal laws.
In addition, the MCDPA does not apply to government entities, nonprofit organizations or higher education institutions.
The MCDPA also exempts the use of personal data for certain specific purposes, such as compliance with the law, preventing fraud or injury to others and defending legal claims, just as in Virginia.
What Obligations Are Imposed?
Under the MCDPA, controllers must:
- Limit the purpose of processing personal data to that which is reasonably necessary and proportional;
- Take steps to implement reasonable safeguards for the personal data within their control;
- Refrain from discriminating against consumers for exercising their rights and from processing personal data in violation of federal laws that prohibit discrimination;
- Be transparent in their reasonably accessible, clear and meaningful privacy notice; and
- Ensure contracts control relationships with their processors (note: the law itself details the minimum necessary provisions of these contracts).
What Consumer Rights Are Created by the MCDPA?
Controllers must provide a now-standard set of consumer rights to Montana consumers:
- Opt-out rights related to the sale of personal data, targeted marketing and profiling (automated decision-making that could have significant legal effects such as related to housing, drinking water, credit, etc.);
- Deletion rights (with respect to the data provided by or about the consumer);
- Access rights, including a right to confirm whether the controller is processing any data at all;
- Correction rights, but limited to data the consumer previously provided;
- Appeal rights;
- Opt-in rights for advertising and targeted marketing to individuals aged 13 to 16; and
- Data portability rights, but limited to data the consumer previously provided.
Sensitive Personal Information
Under the MCDPA, “sensitive data” is considered personal data that includes information such as racial/ethnic origin, religious beliefs, mental or physical health diagnosis, information about a person’s sex life, sexual orientation, citizenship or immigration status, genetic or biometric information used to uniquely identify an individual, personal data collected from a known child (under the age of 13) and precise geolocation (location within a radius of 1,750 feet). Under the MCDPA, a controller may not process (including collection) sensitive data without obtaining the consumer’s consent or, in the case of a child, complying with COPPA.
Response to Consumer Inquiries
As has become something of a standard in state consumer privacy laws, controllers must respond to a consumer personal data request within forty-five (45) days of receipt of the request, with a forty-five (45) day extension available. If a consumer appeals a decision of the controller to deny a consumer request, the appeal response must be delivered within sixty (60) days. As in Virginia, if the appeal is denied, controllers must provide the consumer with a method for contacting the attorney general.
Data Protection Impact Assessments
Just as the laws that the MCDPA is modeled after, controllers will need to document impact assessments before they engage in a number of different processing activities, including: (i) processing for targeted marketing; (ii) sale of personal data; (iii) processing of personal data for profiling if the profiling presents a reasonably foreseeable risk of legal, deceptive, discriminatory, financial, reputational or physical harms; and (iv) processing sensitive data.
The MCDPA allows for the use of impact assessments done under other state laws to count towards the requirements of the MCDPA and does not require retroactive impact assessments for processing activities occurring prior to the effective date of the law. However, the MCDPA requires that assessments must be created or generated on or after January 1, 2025, and are not retroactive.
When Does the MCDPA Take Effect?
The MCDPA comes into effect on October 1, 2024.
***
Creating a successful and effective, comprehensive privacy program for your organization requires a thorough understanding of both the relevant legal obligations and the personal data subject to compliance. Setting up a program that is prepared to respond to various state privacy laws as they come into effect will save organizations time in the long run, especially as many of these laws reflect one another.
If you have questions or need assistance in readiness work for the new state consumer laws, please contact your regular McDermott lawyer or reach out to David Saunders.
Check out our additional coverage on new state consumer privacy laws:
Tennessee Joins the Fray as Legislature Passes Consumer Privacy Law
Indiana Passes Consumer Privacy Bill
Iowa’s New Privacy Law: The Basics
Colorado Finalizes Sweeping New Privacy Rules; Iowa Joins the Fray
Preparing for New Consumer Privacy laws in Colorado, Connecticut and Utah
California Privacy Rights Act Takes Effect…Sort Of

Update Future Financing Act – Focus on Employee Participation in Germany
ARTICLE / CLIENT ALERT
Update Future Financing Act – Focus on Employee Participation in Germany
April 19, 2023
Read time: 6 min
On 12 April 2023, the Federal Ministry of Finance and the Federal Ministry of Justice published the draft bill for a law on the financing of future-proof investments (Zukunftsfinanzierungsgesetz – “ZuFinG-E“).
The draft pursues the ambitious goal of strengthening the performance of the German capital market and increasing the attractiveness of the German financial location in the European financial center through a large number of proposed amendments to company, financial market and tax law.
Among other things, improved tax framework conditions for employee equity participation are intended to make it easier for young companies to attract employees and to hold their own in the international competition for talent.
In the following, we provide an overview of the main proposals for improving the tax framework for employee share ownership in the ZuFinG-E.
FURTHER INFORMATION
The improvement of the tax framework for employee equity participation (hereinafter also referred to as “employee shares“) is intended to make asset formation more attractive for employees. In addition to the increase of the tax exemption, the problem of dry income taxation when granting employee shares is to be alleviated.
I. Increase of the tax exemption for employee shares to € 5,000
The tax exemption for granting employee shares provided for in section 3 no. 39 sentence 1 EStG is to be increased from € 1,440 to € 5,000 per year and per employee (section 3 no. 39 sentence 1 EStG-E).
In order to avoid windfall effects from targeted deferred compensation and to promote long-term participation in the employer company, the following supplementary regulations are intended:
- The allowance is only to be granted if the employee shares are granted in addition to the salary (i.e. exclusion in the case of targeted deferred compensation).
- In case of a sale of the employee shares, the monetary benefit, which is tax-exempt according to section 3 no. 39 EStG, shall only be taken into account as acquisition costs after 3 years (section 20 (4b) EStG-E).
If the employee shares were sold before the minimum holding period of 3 years was reached, there would be no subsequent taxation with wage tax. However, the original tax-exempt amount – for lack of consideration as acquisition costs – would be indirectly subject to the withholding tax (25% plus solidarity surcharge and, if applicable, church tax) due to the higher capital gain.
The increase in the tax-exempt amount would noticeably increase the attractiveness of granting employee shares for both employers and employees. The requirement of a partial sale of shares to cover wage tax (so-called sell to cover) would only be necessary for individual grants of more than € 5,000. This would particularly benefit companies for which a sell-to-cover has so far only been possible with considerable effort due to the low trading volume of their shares.
II. Easier tax deferral when granting employee shares
The ZuFinG-E is also intended to facilitate the possibility of a tax deferral when granting employee shares under Section 19a EStG. Section 19a EStG, introduced in 2021, is intended to make it possible for employees of start-up and growth companies to receive employee shares through tax deferral without dry income taxation. From the point of view of the employer company, this will also have a liquidity-saving effect.
A significant expansion of the scope of application of section 19a EStG is intended:
i) In addition to shares granted by the employer, shares in the employer’s company granted by a shareholder of the employer are also to be favored. This takes into account that employee shares in the employer company are often not granted by the employer company itself but by the (founding) shareholders.
ii) The tax deferral option is to be extended to the granting of shares in affiliated companies of the employer within the meaning of section 18 AktG. In the future, the granting of shares to employees in multi-level group structures would thus also be favored.
iii) The thresholds for classification as a beneficiary employer are to be raised (Section 19a (3) EStG-E):
- In the future, the employer company may not exceed twice the SME threshold (new: less than 500 employees, annual turnover not exceeding € 100 million; annual balance sheet total not exceeding € 86 million). Up to now, the single SME threshold has been applied here.
- The observation period for exceeding the threshold is to be increased from 2 to 7 years.
- The founding of the company must not date back more than 20 years (previously 12 years).
The maximum tax deferral period is to be extended from currently 12 years to 20 years from the date of transfer of the asset interest (Section 19a (4) sentence 1 no. 2 EStG-E). This is also to apply to shares that were and will be transferred before 2024. However, taxation will continue to apply automatically if the employment relationship with the previous employer is terminated (especially in leaver scenarios).
In the future, the employer shall have the right to choose to pay the wage tax on the non-cash benefit at a flat tax rate of 25%, whereby it remains possible to pass on the flat wage tax to the employees. This is intended to alleviate high one-off wage tax burdens. The tax exemption under section 3 no. 39 EStG would be taken into account in advance to reduce the tax burden.
In the case of a repurchase of the shares by the employer, not the common value of the shares but the remuneration granted by the employer is to apply for the determination of the basis of assessment (Section 19a (4) sentence 4 2nd half sentence EStG-E). Here, too, the common practice is taken into account, according to which (bad) leaver regulations regularly provide for a value determination for the reacquisition that deviates from the common value.
III. Outlook
The draft bill on the ZuFinG is now subject to interdepartmental coordination and is expected to enter into force as early as 2024 after the completion of the legislative process. We look forward to keeping you informed about the developments of the ZuFinG!

OCR Issues Proposed Rule to Modify HIPAA Privacy Rule to Include Explicit Protections for Reproductive Healthcare
ARTICLE / CLIENT ALERT
OCR Issues Proposed Rule to Modify HIPAA Privacy Rule to Include Explicit Protections for Reproductive Healthcare
April 20, 2023
Read time: 9 min
On April 12, 2023, the US Department of Health and Human Services (HHS) Office for Civil Rights (OCR) issued a notice of proposed rulemaking detailing its proposal to modify the HIPAA Privacy Rule (Proposed Rule). The Proposed Rule comes as a part of the Biden administration’s response to the US Supreme Court’s ruling in Dobbs v. Jackson Women’s Health Organization.
The Proposed Rule would provide special protections for protected health information (PHI) related to reproductive healthcare. Following the Dobbs decision, many healthcare providers expressed concerns that PHI related to reproductive healthcare may be sought by state and local governments for use in criminal, civil or administrative investigations or proceedings. OCR noted that such compelled uses and disclosures of PHI could have a chilling effect on lawfully obtained healthcare and erode trust in confidential communications between a patient and provider. Additionally, providers could elect to leave out critical details from a patient’s medical record if they fear the information could later be used by a state or local government actor against the patient.
Stakeholders may submit comments on the proposed rule on or before June 16, 2023.
Generally, the Proposed Rule seeks to provide heightened protections for PHI “sought for the purposes of conducting a criminal, civil, or administrative investigation into or proceeding against any person in connection with seeking, obtaining, providing, or facilitating reproductive healthcare that is lawful under the circumstances in which is it provided.”
- Definitions. The Proposed Rule makes several definition changes to terms in the existing Privacy Rule and adds clarification to others, including the following:
- “Person”: OCR proposes to clarify that the meaning of “person” for purposes of the Social Security Act, HIPAA and the Privacy Rule (and other related HIPAA rules) is consistent with that found in 1 U.S.C. § 8, which excludes a fertilized egg, embryo or fetus from the definition of “person” and “child.” Accordingly, OCR proposes to clarify that “natural person” as used in the definition of “person” is limited to the definition at 1 U.S.C. § 8.
- “Reproductive Health Care”: OCR proposes to add “reproductive health care” as a sub-category of the existing term “health care.” OCR proposes to define “reproductive health care” as “care, services, or supplies related to the reproductive health of the individual.” OCR states in the preamble guidance to the Proposed Rule that the definition would apply broadly to include not only reproductive healthcare services provided by healthcare providers and prescription supplies but would also include care, services and supplies furnished by “other persons and non-prescription supplies purchased in connection with an individual’s reproductive health.” OCR also states that the definition is intended to include all specified services no matter where a patient receives them, and all types of services, rather than only certain types in a listed definition. OCR is not proposing a separate definition of “reproductive health” but notes in the preamble that the definition of “reproductive health care” would include all types of healthcare related to an individual’s reproductive system, including, but not limited to: contraception, including emergency contraception; pregnancy-related healthcare; fertility or in-fertility related care; and other types of care, services or supplies used for the diagnosis and treatment of conditions related to the reproductive system. Pregnancy-related healthcare includes, but is not limited to, miscarriage management, molar or ectopic pregnancy treatment, pregnancy termination, pregnancy screening, products related to pregnancy, prenatal care and similar or related care. Fertility or infertility-related healthcare would also be interpreted to include services such as assisted reproductive technology and its components, as well as other services or supplies used for the diagnosis and treatment of infertility. This definition would also encompass other types of care, services or supplies used for the diagnosis and treatment of conditions related to the reproductive system or reproductive organs, regardless of whether the healthcare is related to an individual’s pregnancy or whether the individual is of reproductive age. This could potentially extend the protections of the Proposed Rule to individuals seeking gender-affirming care in states where permitted when the individual lives in a state where such care is not permissible.
- Prohibited Use and Disclosure of PHI. OCR proposes to prohibit regulated entities from using or disclosing an individual’s PHI for use against any individual, regulated entity or other person for the purpose of a criminal, civil or administrative investigation into or proceeding against such person in connection with seeking, obtaining, providing or facilitating reproductive healthcare that is lawful under the circumstances in which it is provided. The Proposed Rule also prohibits such use for initiating an investigation or proceeding. This use would not be permitted even with authorization. The prohibition is focused on the intended purpose of the use or disclosure of the information and not the type of PHI requested or disclosed. In that regard, OCR proposes to clarify that nothing in the Privacy Rule, as it would be amended by the Proposed Rule, is intended to prohibit a use or disclosure of PHI otherwise permitted by the Privacy Rule unless the use or disclosure is primarily for the purpose of investigating or imposing liability on a person for seeking, obtaining, providing or facilitating reproductive healthcare.
- Attestation. The use and disclosure of PHI related to reproductive healthcare to a law enforcement or regulatory agency would be permissible in connection with civil, criminal or administrative proceedings only where the Covered Entity has received an attestation from the person requesting the use and disclosure. The attestation would have to be signed, dated and include a written statement that the disclosure is not for a prohibited use. Even if a permissible use of PHI applies, the attestation would have to include a statement that it is not being used for a prohibited purpose regarding reproductive healthcare. An attestation under the Proposed Rule would need to be clearly labeled and distinct from any other attestation or documentation. A regulated entity would not be obligated to investigate the validity of an attestation, and it could instead rely on the validity of the attestation itself if it is objectively reasonable to do so.
- Notice of Privacy Practices. OCR is proposing to add two types of prohibited uses and disclosures to the required Notice of Privacy Practices. Covered Entities would be required to indicate in their notices that they are prohibited from using and disclosing reproductive health information for: (1) criminal, civil or administrative investigations into or proceedings against seeking, obtaining, providing or facilitating lawful reproductive healthcare; or (2) identifying any person for the purpose of initiating such an investigation or proceeding.
Key Takeaways
- The definition of “reproductive health care” in the Proposed Rule notably does not explicitly include abortion. The Proposed Rule’s definition of reproductive healthcare is “care, services, or supplies related to the reproductive health of the individual.” While intended to broadly capture a wide variety of services, such a definition lacks specificity and may open the door for future debate about whether abortion services are included under the definition, even though it is clear that the Biden administration intends that abortion services would be covered. Both HHS and the White House issued statements explicitly stating that the proposal includes abortion care. The comment period presents an opportunity for commenters to make suggestions as to what should be included in the definition of reproductive healthcare, including adding further specificity to avoid potential ambiguities or debates following any eventual final rule.
- The Proposed Rule would appear to establish a primary purpose test for purposes of determining whether a regulated entity may make uses or disclosures of PHI that are otherwise permitted under the Privacy Rule—i.e., by inquiring whether the use or disclosure is primarily for the purpose of investigating or imposing liability on a person for seeking, obtaining, providing or facilitating reproductive healthcare.
- The Proposed Rule will require updates to the Notice of Privacy Practices. These updates will be in addition to the significant updates already contemplated by the 42 C.F.R. Part 2 proposed rule, which we have detailed in a separate On the Subject. Commenters may want to encourage OCR to implement the changes contemplated by the Proposed Rule to the Notice of Privacy Practices at the same time as the Part 2 proposed rule so that Covered Entities are not forced to make piecemeal changes to their notices
- The rule permits Covered Entities to disclose PHI under Section 164.512 if a regulatory or law enforcement agency attests to the Covered Entity that the purpose of the request for information is not primarily tied to an individual seeking reproductive healthcare. OCR, however, has limited enforcement levers with which to hold state law enforcement or regulatory agencies to their attestations. Therefore, while perhaps a state law enforcement or regulatory agency may initially attest to a regulated entity that the purpose of the request for information is permissible under HIPAA, it is unclear what repercussions such agency would face if it then in fact used the PHI as part of an investigation or proceeding regarding an individual concerning reproductive healthcare.
- The Privacy Rule preempts conflicting state law, which may prevent enforcement of certain contrary state laws. Violations by regulated entities could result in OCR investigations or civil monetary penalties. Such discussions in the Proposed Rule indicate that OCR may be willing to use its enforcement tools to ensure that the rule, if finalized, is applied even in states where state law may otherwise allow the use of PHI for investigatory purposes or in civil, criminal or administrative proceedings.
Please contact the authors or your regular McDermott lawyer if you are interested in assistance in submitting comments to the Proposed Rule or if you have any questions concerning its implications.

Biden-Harris Administration’s Proposed Vehicle Pollution Standards Will Spur EV Adoption, Cut Nearly 10 Billion Tons of CO2 Emissions
ARTICLE / CLIENT ALERT / US POLICY
Biden-Harris Administration’s Proposed Vehicle Pollution Standards Will Spur EV Adoption, Cut Nearly 10 Billion Tons of CO2 Emissions
April 18, 2023
Read time: 3 min
As part of its push to transition the American automotive industry to electric vehicles (EVs), the Biden-Harris administration has proposed two new vehicle pollution standards. The first rule targets greenhouse emissions from passenger cars, vans and light trucks from model years 2027 through 2032, while the second rule intends to update emissions standards for greenhouse gas emissions from buses, freight trucks and other heavy-duty vehicles from model years 2028 through 2032.
The US Environmental Protection Agency (EPA) estimates that the proposed vehicle pollution standards will cut nearly 10 billion tons of CO2 emissions (twice the annual US emissions), save consumers an average of $12,000 over the lifetime of a vehicle, reduce reliance on imported oil by 20 billion barrels and strengthen US energy security. Without directly saying so, the proposed regulations seem fully intended to begin the phase-out of internal combustion engines.
Key Takeaways:
- The proposed standards will make all vehicles, including gas-powered cars and heavy-duty trucks, cleaner and more efficient.
- The rules are technology-neutral, which means that manufacturers investing in EVs will have an easier time meeting standards. However, with rapidly improving technology and an increase in consumer demand, many manufacturers will likely rely on fully electric vehicles for compliance.
- The proposed rules could result in the electrification of 67% of new sedans, crossovers, SUVs and light trucks; 50% of new vocational vehicles (such as buses and garbage trucks); 35% of new short-haul freight tractors and 25% of new long-haul freight tractors by 2032.
- The administration’s goal is that at least 50% of all new passenger cars and light trucks sold in 2030 be zero-emission vehicles, and 100% of all new medium- and heavy-duty vehicles sold in 2040 be zero-emission vehicles.
- Manufacturers should expect supply chain delays and potential consumer hesitation as challenges to complying with the new rules.
- The proposed standards are subject to the ordinary public comment period.
While certain manufacturers and suppliers have expressed concerns that the proposed rules are overly aggressive, the decisive move by the Biden-Harris administration and the EPA reflects years of progress among corporate, federal, state and local stakeholders to square their interests on the EV transition. The administration’s push toward EV adoption reflects a larger effort to address climate change. The billions of dollars in funding carved out for EV charging and battery manufacturing in the Infrastructure Investment and Jobs Act, as well as the enhanced tax incentives in the Inflation Reduction Act of 2022, have helped lay the groundwork for a homegrown EV industry backed by US jobs and manufacturing.

Tri-Agencies Address Preventive Services Coverage in the Wake of Braidwood
ARTICLE / CLIENT ALERT
Tri-Agencies Address Preventive Services Coverage in the Wake of Braidwood
April 18, 2023
Read time: 5 min
In response to Braidwood Mgmt. Inc. v. Becerra, a recent case striking down part of the Affordable Care Act (ACA) preventive services mandate, the US Departments of Labor, Health and Human Services, and the Treasury (collectively, the Departments) issued a set of Frequency Asked Questions (FAQs) anticipating and responding to questions from stakeholders. In the FAQs (available here), the Departments also clarified that they disagree with the Braidwood ruling and strongly encourage plans and issuers to continue to cover preventive services without cost sharing.
BRAIDWOOD MGMT.
Braidwood involves a challenge to Section 2713 of the Public Health Service (PHS) Act (as added by the ACA), which among other things requires non-grandfathered group health plans and health insurance issuers offering non-grandfathered group or individual health insurance coverage to cover certain preventive services without cost sharing. The case was brought by a Christian-owned business that objected to covering pre-exposure prophylaxis (PrEP)—a medication that prevents the acquisition of HIV. PrEP was elevated to the level of a preventive service in June 2019 when it was assigned “Grade A” by the United States Preventive Services Task Force (USPSTF).
On March 30, 2023, the United States District Court for the Northern District of Texas issued a final judgment in Braidwood, vacating a portion of the ACA preventive services mandate. The court had previously determined that certain portions of the mandate were unconstitutional and violated religious rights but reserved a decision regarding remedies. The most recent decision held that the USPSTF’s recommendations violate the Appointments Clause of Article II of the United States Constitution and are therefore unlawful. The court’s order vacated all actions taken by the Departments to implement or enforce the ACA’s preventive services mandate, as recommended by USPSTF on or after March 23, 2010. The ruling applies nationwide and effectively freezes the list of preventive measures in place as of March 23, 2010. The US Department of Justice filed a notice of appeal on March 31, 2023, and a motion for a stay on April 12, 2023.
THE DEPARTMENTS’ FAQS
The FAQs clarify the following:
- Plans and issuers must continue to provide coverage, without cost sharing, for items and services recommended with an “A” or “B” rating by the USPSTF before March 23, 2010. Noting that “the USPSTF has updated a significant number of the recommendations since March 23, 2010,” the Departments anticipate providing additional guidance on the subject;
- Braidwood does not preclude plans and issuers from continuing to provide the full extent of preventive services coverage without cost sharing, including items and services recommended with an “A” or “B” rating by the USPSTF on or after March 23, 2010, and the Departments strongly encourage continuation of such coverage;
- Plans and issuers must continue to cover immunizations recommended by the Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention (CDC) and preventive care and screenings provided for in comprehensive guidance supported by the Health Resources and Services Administration (HRSA), which include, but are not limited to, immunizations recommended by ACIP (including any such COVID-19 vaccines), as well as contraceptive services, breastfeeding services and supplies, cervical cancer screening, and pediatric preventive care recommended by HRSA, without cost sharing, consistent with all applicable regulations and guidance. The Departments also noted that some of these recommendations and guidelines overlap with items and services recommended with an “A” or “B” rating by the USPSTF on or after March 23, 2010, in which case plans and issuers must provide coverage without cost sharing;
- Until further guidance is issued, items and services recommended with an “A” or “B” rating by the USPSTF on or after March 23, 2010, will be treated as preventive care for purposes of high-deductible health plan coverage and Health Savings Account eligibility; and
- Braidwood does not affect state laws that require coverage without cost sharing of items and services recommended with an “A” or “B” rating by the USPSTF on or after March 23, 2010; thus, plans and issuers generally must continue to comply with any applicable state laws.
The FAQs also address the question of the timing of changes required by the ruling, explaining that to the extent a plan or issuer is permitted and elects to make changes to coverage, the plan or issuer must comply with all applicable notice requirements (e.g., advance notice for changes to Summaries of Benefits and Coverage).
ACTION ITEMS
The FAQs clarify that plans and issuers are not required to make any changes to the preventive services that they cover without cost sharing as a result of Braidwood, and the Departments strongly encourage plans and issuers to continue covering the full scope of preventives services. Any plans or issuers considering changes to their preventive services coverage should tread carefully to ensure that they do not inadvertently violate the surviving parts of the ACA preventive services mandate and/or any applicable state laws. In addition, it remains to be seen if Braidwood will survive on appeal.
If the Braidwood decision survives, plans would no longer be required to cover without cost sharing any service that was first recommended by USPSTF on or after March 23, 2010 (and is not also recommended by another group like HRSA or ACIP). For a summary of the preventive services effected by the decision, please see “Major Additions and Revisions to USPSTF Recommendations Made On or After March 23, 2010” published by the Kaiser Family Foundation (available here).
For any questions, please contact your regular McDermott lawyer or one of the authors.

Illinois House Passes Legislation to Increase State Oversight of Healthcare Consolidation
ARTICLE / CLIENT ALERT
Illinois House Passes Legislation to Increase State Oversight of Healthcare Consolidation
April 18, 2023
Read time: 11 min
On March 24, 2023, the Illinois House of Representatives passed legislation (HB 2222) that, if passed by the Illinois Senate and signed by Governor J.B. Pritzker, would increase oversight of certain “covered transactions” for healthcare facilities and provider organizations, effective January 1, 2024. Unlike the federal Hart-Scott-Rodino (HSR) Act, which requires notice to the federal antitrust agencies for transactions valued over a certain dollar amount threshold, HB 2222 has no minimum transaction value threshold for intrastate covered transactions and would require reporting even for small transactions that are unlikely to raise antitrust concerns. The Illinois Attorney General’s Office (IL AG) asserts that the legislative intent is to establish a review process to assess a transaction’s impact on cost, quality and access to care.
Proposed Legislation
The two chambers of the Illinois legislature proposed separate bills in 2023 to establish a review process for the IL AG to assess a transaction’s impact on cost, quality and access to care: SB 1766 and HB 2222. HB 2222 has had more traction and, as of the date of this On the Subject, was presented before the Senate’s Assignments Committee. Accordingly, this On the Subject focuses on HB 2222.
HB 2222 would provide the IL AG with additional tools to exercise oversight over a broad array of transactions that involve healthcare facilities through amendments to the Illinois Antitrust Act, the State Finance Act and the Illinois Health Facilities Planning Act.
Illinois Antitrust Act Amendments
HB 2222 would amend the Illinois Antitrust Act to add the new transaction reporting requirement. The Illinois Antitrust Act prohibits certain restraints of trade and monopolistic practices. In addition to a private right of action, the IL AG has the authority to pursue criminal and civil violations of the Illinois Antitrust Act.
HB 2222 would require 30 days’ prior notice to the IL AG of any merger, acquisition or contracting affiliation between two or more healthcare facilities or provider organizations not previously under common ownership or contracting affiliation (covered transactions). Covered transactions would also include those between an Illinois healthcare entity and an out-of-state healthcare entity when the out-of-state entity generates $10 million or more in annual revenue from patients residing in Illinois.
HB 2222 defines “healthcare facilities” broadly to include entities such as the following:
- Ambulatory surgery treatment centers
- Hospitals and other locations or operations licensed under the Hospital Licensing Act
- Outpatient surgery centers
- Kidney disease treatment centers
- Any other institution, place, building or room used for provision of healthcare category or services defined under the Illinois Health Facilities Planning Act, including cardiac catheterization and open-heart surgery.
HB 2222’s “provider organizations” definition is also broad and includes any corporation, partnership, business trust, association or organized group of persons whether incorporated or not, in the business of healthcare delivery or management, that represents 20 or more healthcare providers in contracting with health carriers or third-party administrators for the payment of healthcare services. This would include physician organizations, physician hospital organizations, independent practice associations, provider networks and accountable care organizations, and would exclude facilities operating as part of a physician practice or groups of other licensed healthcare professionals, or where such practices are operated within a portion of a healthcare facility.
A “contracting affiliation” would mean the formation of a relationship between two or more entities that permits the entities to negotiate jointly with health carriers or third-party administrators over rates for professional medical services, or permits one entity to negotiate on behalf of the other entity with health carriers or third-party administrators over rates for professional medical services. Contracting affiliations do not include arrangements among entities under common ownership.
If HB 2222 is signed into law in its current form, any healthcare facility or provider organization that is a party to a covered transaction and files a premerger notification to the federal antitrust enforcement agencies in compliance with HSR Act must simultaneously provide a copy of such filing to the IL AG. When a transaction is not covered by the HSR Act, a healthcare facility would satisfy its notice obligations to the IL AG under HB 2222 by filing an application for a change of ownership with the Illinois Health Facilities and Services Review Board (Review Board) in compliance with the Illinois Health Facilities Planning Act. In that scenario, the healthcare facility would not need to provide separate notice to the IL AG, because the Review Board would provide a copy to the IL AG at the same time that it provided such notice to other stakeholders, as required by Section 8.5(a) of the Health Facilities Planning Act (as described in more detail below).
Any healthcare facility or provider organization that is party to a covered transaction not described above (i.e., a transaction that does not require a filing under the HSR Act or a change of ownership filing with the Review Board) would be required to provide written notice to the IL AG that includes the following:
- The names of the parties and their current business address
- Identification of all locations where healthcare services are currently provided by each party
- A brief description of the nature and purpose of the proposed transaction
- The anticipated effective date of the proposed transaction.
The IL AG may request additional information, as it determines necessary, within 30 days of receiving notice of the covered transaction. If the IL AG requests additional information, the covered transaction may not proceed until 30 days after the parties have substantially complied with the request. Any subsequent IL AG request for additional information would not result in any additional delay of the covered transaction.
Amendments to the Illinois Antitrust Act would also provide that, should the IL AG investigate any act or practices prohibited by the Antitrust Act, all documentary material, transcripts, oral testimony and answers to interrogatories obtained may be used by the IL AG in any administrative or judicial action or proceeding, and all such information, as well as information produced pursuant to the new reporting requirement, shall be treated as if produced pursuant to a subpoena for purposes of maintaining the confidentiality of such information.
Failure to comply with the IL AG notice requirements and responses to IL AG requests for additional information would expose the healthcare facility or provider organization to a penalty of $500 for each day in violation, after a 10-day cure period. The IL AG would also have the right to seek a temporary restraining order or injunctive relief to prevent the organization from continuing its noncompliance or doing “any act in furtherance thereof.”
Illinois Finance Act Amendments
HB 2222 would amend the Illinois Finance Act to establish a new antitrust enforcement fund to be used for Illinois Antitrust Act enforcement. The penalties described above would be deposited into the fund.
Health Facilities Planning Act Amendments
HB 2222 would amend Section 8.5(a) of the Health Facilities Planning Act to add a requirement for notice to the IL AG for change of ownership of a healthcare facility, aligning with the changes to the Antitrust Act. The proposed legislation would require that, upon the Review Board’s finding that an application for a change of ownership is complete, notice of the same be delivered to the IL AG in the same manner and at the same time as notice of such transactions is delivered to the state representative and state senator of the district in which the healthcare facility is located and posted to the Review Board’s website.
Comparison to SB 1766
SB 1766 is more onerous than HB 2222 in several ways:
- It would require 60 rather than 30 days’ prior notice to the IL AG of a covered transaction.
- It would require submission of all transaction agreements, including ancillary agreements, and financial/economic analyses that the party reviewed or relied on in negotiating the transaction.
- It defines a much lower number of providers that make up a “provider organization,” as compared to HB 2222.
As discussed above, however, it appears that HB 2222 is the bill on this subject that will proceed.
Precedent
HB 2222, if signed into law, would place Illinois squarely among the states that require AG review of certain healthcare transactions. Some states have longstanding AG review and approval processes, while others have adopted such requirements more recently, such as the state of Washington in January 2020 (in fact, SB 1766 and the first iteration of HB 2222 reflect requirements and thresholds similar to those enacted in Washington, such as 60-day advance notice of acquisitions, mergers and contracting affiliations involving two or more hospitals/hospital systems or provider organizations, and a seven provider threshold for defined “provider organizations”). The timing of the review process enacted in Washington, and the similarities to SB 1766 and HB 2222 as initially introduced, may not be coincidental.
Anticipated Impact if HB 2222 Is Passed in Its Current Form
The IL AG has the existing authority to investigate transactions and pursue criminal and civil violations of the Illinois Antitrust Act. Like other state AGs, the IL AG presently coordinates with the federal antitrust enforcement agencies on merger investigations, including those that are HSR reportable and those that are not. The biggest impact of HB 2222, if it passes, is that the IL AG would receive affirmative notice of covered transactions and would have the opportunity to investigate transactions that otherwise might not have come to its attention.
Potential for Transaction Delays
As proposed, this new IL AG affirmative review process appears to have the potential to delay the closing of covered transactions in Illinois for an indeterminate period of time. Based on the timeline outlined in HB 2222, if a healthcare facility or provider organization gives the IL AG the required notice of a covered transaction 30 days (or event slightly more) in advance of the covered transaction’s planned closing date, and the IL AG requests additional information near the end of the 30-day period after it receives such notice, the parties would be barred from closing the transaction until they substantially comply with the IL AG’s post-notice request and an additional 30 days have passed—thereby extending the timing of closing. HB 2222’s lack of specificity regarding how to determine whether a response to the IL AG meets “substantial compliance” poses potential risk for even more delay. If “substantial compliance” is determined solely in the discretion of the IL AG, the review process could be extended for however long it takes the IL AG to make such determination, and there appears to be no check on that power.
HB 2222 also provides the IL AG with the right to seek a temporary restraining order or injunctive relief to prevent an organization from continuing its noncompliance or doing “any act in furtherance thereof,” which, if such relief is sought in advance of closing a transaction, could delay closing until the temporary restraining order or other relief was lifted.
Scope of Potential Covered Transactions
HB 2222 does not define the scope of “healthcare providers” within the definition of a “provider organization.” If the Illinois legislation that is ultimately passed follows that of certain other states (including Washington), and the ultimate definition includes a wide range of licensed healthcare professionals, then the scope of covered transactions could be very broad. With broad definitions resulting in a broader swath of transactions requiring notices to the IL AG, there also is a risk that the IL AG could become inundated with notices to process, even if the implicated transactions cause little to no concern from a quality, access or cost perspective. Similarly, the definition of “contracting affiliations” offers a broad range of relationships and entity types and captures healthcare affiliations that may not be intended by the drafters of HB 2222.
Transaction Planning
If and when this bill becomes law, healthcare facilities and provider organizations that are concerned about potential delays or onerous requests for information should consult with their legal counsel to determine the appropriate time to file the required notice. In some circumstances, parties may wish to consider requesting a dialogue with the IL AG in advance of providing written notice, to preview the covered transaction before the mandatory preclosing notice date, in order to avoid surprises and potentially streamline review time. Currently it is unclear whether the IL AG would accept requests for dialogue in advance of providing the written notice—a practice that is common in states with similar notice requirements. Healthcare facilities and provider organizations should also consult with their legal advisors to determine the best approach to reply to an initial request for additional information from the IL AG to increase likelihood of achieving substantial compliance and the ability to timely close the transaction.
McDermott will be following the evolution of HB 2222 and will update this On the Subject as developments arise.
